Quantum appoints national account manager

Pauline Carter brings 18 years’ experience to the role

Quantum Pharmaceutical, a UK-based pharmaceutical specials manufacturer, has appointed Pauline Carter as national account manager. Carter brings more than 18 years’ industry experience to the role.

Carter has previously been responsible for increasing retail sales and negotiating new sales opportunities for a number of international pharmacy companies including AAH Pharmaceuticals and Mylan. She has also worked as a prescribing technician for Central Cheshire Primary Care Group.

The company says Carter’s industry credentials and experience of working in both hospital and retail pharmacy will enable the firm to extend its partnerships with hospitals and dispensing doctors.

You may also like

Finance

Moderna partners with Recordati to commercialise propionic acidemia mRNA therapy

The pair have entered a strategic collaboration to advance and globally commercialise its investigational propionic acidemia treatment mRNA-3927, with Moderna leading clinical development and manufacturing and Recordati responsible for worldwide commercialisation
Finance

AstraZeneca strengthens weight management pipeline with CSPC Pharmaceuticals collaboration

The pair have signed a strategic collaboration covering eight obesity and type 2 diabetes programmes, including a clinical-ready GLP-1/GIP asset, AI-driven peptide discovery capabilities and injectable dosing technology
Finance

Ardena divests Södertälje API site to Nanologica

The divestment of the company's drug substance manufacturing site in Sweden to Nanologica is part of a strategic move to focus investment on specialised CDMO capabilities supporting precision medicines
Finance

Global consortium launches to accelerate antibiotic discovery

The $60m consortium backed by the Gates Foundation, Novo Nordisk Foundation and Wellcome aims to speed the discovery of next-generation antibiotics to tackle the growing threat of antimicrobial resistance
Research & Development

EMBO Installation Grant supports new genome editing lab at Vilnius University

Dr C. Patinios Awarded EMBO Installation Grant to advance genome editing research in Lithuania
Manufacturing

Sharp Services invests more than €20m to expand injectables packaging capacity at its European facilities

Expansion includes significant cold chain warehouse capacity to support injectable formats
Finance

Syngene International extends long-term research collaboration with Bristol Myers Squibb until 2035

Syngene International, a global contract research, development, and manufacturing organisation (CRDMO), announces the extension of its long-standing strategic collaboration with Bristol Myers Squibb through 2035
Subscribe now